Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization - Archive ouverte HAL Access content directly
Journal Articles Advanced Healthcare Materials Year : 2024

Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization


Abstract Nanoparticle (NP) surface functionalization with proteins, including monoclonal antibodies (mAbs), mAb fragments, and various peptides, has emerged as a promising strategy to enhance tumor targeting specificity and immune cell interaction. However, these methods often rely on complex chemistry and suffer from batch‐dependent outcomes, primarily due to limited control over the protein orientation and quantity on NP surfaces. To address these challenges, a novel approach based on the supramolecular assembly of two peptides is presented to create a heterotetramer displaying V H Hs on NP surfaces. This approach effectively targets both tumor‐associated antigens (TAAs) and immune cell‐associated antigens. In vitro experiments showcase its versatility, as various NP types are biofunctionalized, including liposomes, PLGA NPs, and ultrasmall silica‐based NPs, and the V H Hs targeting of known TAAs (HER2 for breast cancer, CD38 for multiple myeloma), and an immune cell antigen (NKG2D for natural killer (NK) cells) is evaluated. In in vivo studies using a HER2+ breast cancer mouse model, the approach demonstrates enhanced tumor uptake, retention, and penetration compared to the behavior of nontargeted analogs, affirming its potential for diverse applications.
No file

Dates and versions

hal-04516112 , version 1 (22-03-2024)



Clélia Mathieu, Shayamita Ghosh, Julien Draussin, Adeline Gasser, Guillaume Jacquot, et al.. Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization. Advanced Healthcare Materials, 2024, ⟨10.1002/adhm.202304250⟩. ⟨hal-04516112⟩
0 View
0 Download



Gmail Facebook X LinkedIn More